Fortis Healthcare Ltd

Fortis Health. Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Fortis Healthcare Ltd

₹ 732 1.99%
03 Jan - close price
fortishealthcare.com BSE: 532843 NSE: FORTIS
About

FHL was incorporated in February 1996. The company’s first healthcare facility became operational in Mohali, Punjab in 2001. It is a leading integrated healthcare service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates its healthcare delivery services in India, Nepal, Dubai and Sri Lanka with 36 healthcare facilities with approximately 4,000 operational beds. [1]

Company controls its diagnostics business through its 57% owned subsidiary SRL Limited. It is amongst the largest private diagnostics chains. It has a presence in over 600 cities and towns, with an established strength of 415 laboratories, 8,200 direct clients and 1,400 Collection Centers. [2]

Key Points

Network[1]
Fortis operates 27 hospitals (including JVs) with ~4,500 operational beds, 5,500+ Doctors, 6,500+ Nurses and ~24,000 employees (including Agilus). 4 facilities are JCI accredited and 21 NABH Accredited.
**State-wise Beds Split - **
NCR - 1722
West Bengal - 335
Chattisgarh - 70
Karnataka - 620
Maharashtra - 770
Rajasthan - 275
Punjab - 774

Website BSE NSE
  • Market Cap ₹ 55,267 Cr.
  • Current Price ₹ 732
  • High / Low ₹ 744 / 375
  • Stock P/E 292
  • Book Value ₹ 120
  • Dividend Yield 0.14 %
  • ROCE 2.41 %
  • ROE 1.37 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Company has been maintaining a healthy dividend payout of 38.8%

Cons

  • Stock is trading at 6.09 times its book value
  • Company has a low return on equity of 0.69% over last 3 years.
  • Earnings include an other income of Rs.168 Cr.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Healthcare Industry: Healthcare

Part of BSE 250 LargeMidCap Index Nifty LargeMidcap 250 BSE 400 MidSmallCap Index Nifty Total Market Nifty Midcap 150

Edit Columns
Loading peers table ...

Quarterly Results

Standalone Figures in Rs. Crores / View Consolidated

Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024
221 228 210 247 266 262 277 289 294 291 307 333 357
188 190 191 215 228 226 250 254 255 242 238 275 297
Operating Profit 33 38 19 32 38 36 28 35 40 49 69 58 60
OPM % 15% 17% 9% 13% 14% 14% 10% 12% 13% 17% 23% 17% 17%
33 35 16 19 106 42 30 31 110 32 65 35 36
Interest 32 32 33 28 28 25 25 23 21 19 18 17 16
Depreciation 28 28 28 28 29 29 29 25 25 25 26 26 27
Profit before tax 6 14 -27 -5 87 24 3 18 104 36 90 50 52
Tax % 34% 37% -9% 51% 5% 18% 41% 27% 8% 36% 24% 47% 24%
4 9 -24 -8 82 19 2 13 95 23 68 27 40
EPS in Rs 0.06 0.11 -0.32 -0.10 1.09 0.26 0.03 0.17 1.26 0.30 0.91 0.36 0.52
Raw PDF

Profit & Loss

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
353 369 611 612 645 659 656 702 633 863 1,053 1,181 1,289
353 449 758 737 792 697 780 633 605 747 919 988 1,053
Operating Profit -0 -80 -148 -125 -146 -38 -123 69 28 116 134 193 236
OPM % -0% -22% -24% -20% -23% -6% -19% 10% 4% 13% 13% 16% 18%
189 229 220 166 165 70 522 809 248 118 197 236 168
Interest 134 91 81 65 106 64 192 160 141 130 106 82 71
Depreciation 23 17 27 25 27 29 27 97 111 113 116 101 105
Profit before tax 32 41 -36 -50 -114 -60 180 621 24 -9 109 247 228
Tax % 46% 42% -5% -19% -34% 6% 31% 17% 83% 48% 12% 19%
17 24 -34 -40 -75 -64 123 513 4 -13 96 199 158
EPS in Rs 0.43 0.52 -0.73 -0.87 -1.44 -1.23 1.63 6.80 0.06 -0.18 1.27 2.64 2.09
Dividend Payout % 0% 0% 0% 0% 0% 0% 0% 0% 0% 0% 78% 38%
Compounded Sales Growth
10 Years: 12%
5 Years: 12%
3 Years: 23%
TTM: 15%
Compounded Profit Growth
10 Years: 24%
5 Years: 0%
3 Years: 80%
TTM: 190%
Stock Price CAGR
10 Years: 21%
5 Years: 41%
3 Years: 37%
1 Year: 69%
Return on Equity
10 Years: 1%
5 Years: 2%
3 Years: 1%
Last Year: 1%

Balance Sheet

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
Equity Capital 405 463 463 463 518 519 755 755 755 755 755 755 755
Reserves 2,796 3,247 3,217 3,284 3,754 3,708 7,608 8,122 8,127 8,114 8,209 8,332 8,322
1,018 1,279 1,234 1,076 647 555 1,478 1,361 1,380 1,193 785 659 581
259 171 246 215 242 234 279 343 320 365 620 640 729
Total Liabilities 4,478 5,160 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,387 10,388
118 146 190 172 186 203 180 906 853 770 492 467 668
CWIP 73 121 169 182 199 166 165 33 7 6 3 260 119
Investments 2,406 2,795 2,411 2,428 3,603 3,658 8,310 8,153 8,898 8,845 8,848 8,834 8,754
1,882 2,097 2,389 2,257 1,174 989 1,466 1,489 824 804 1,027 825 848
Total Assets 4,478 5,160 5,159 5,039 5,161 5,016 10,120 10,581 10,582 10,426 10,369 10,387 10,388

Cash Flows

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
1 -45 -144 -761 22 -15 -61 100 32 76 198 218
312 -521 294 394 -72 245 -4,688 810 28 238 205 44
-219 484 -170 370 45 -292 4,792 -972 6 -320 -395 -245
Net Cash Flow 95 -82 -20 3 -5 -62 43 -62 66 -6 8 18

Ratios

Standalone Figures in Rs. Crores / View Consolidated

Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Debtor Days 96 86 57 61 43 39 47 42 43 32 34 41
Inventory Days 17 16 18 15 14 19 17 25 21 25 18 15
Days Payable 170 172 240 289 340 392 542 525 520 494 572 608
Cash Conversion Cycle -57 -70 -165 -213 -284 -334 -479 -457 -456 -438 -520 -553
Working Capital Days 525 1,283 354 84 44 -23 19 7 45 25 32 -29
ROCE % 4% 3% 0% 1% -0% 1% 5% 9% 1% 1% 2% 2%

Shareholding Pattern

Numbers in percentages

Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17% 31.17%
30.08% 29.82% 29.66% 30.59% 31.01% 31.22% 30.03% 26.31% 23.72% 23.24% 23.31% 25.26%
15.67% 16.90% 17.60% 20.02% 20.38% 20.69% 22.17% 26.55% 29.42% 31.14% 32.31% 30.73%
23.08% 22.12% 21.57% 18.22% 17.44% 16.92% 16.65% 15.97% 15.71% 14.44% 13.22% 12.83%
No. of Shareholders 1,54,5721,56,8811,60,7621,58,4551,43,5191,37,8941,35,0471,31,5161,35,6641,57,1651,54,2602,04,184

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls